Search

everythinglearnresearchcommunity

for

Search:↓

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Some medications can cause acne, and stopping these drugs is the main treatment.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Early hair loss may indicate prostate issues.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.